SIGN UPLog In

General

Financials

People

Founders
Employee Profiles

Activity

Recent News

Last deal

$185M

Amount

Post-IPO Equity

Stage

27.03.2024

Date

3

all rounds

$231.5M

Total amount

date founded

Financing round

General

About Company
Avalo Therapeutics is a clinical-stage biopharmaceutical company that develops highly targeted therapeutics for unmet clinical needs.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2011

founders

Number of employees

11-50

Last funding type

Post-IPO Equity

IPO status

Private

Description

Utilizing a precision medicine approach, Avalo Therapeutics discovers, develops, and commercializes innovative therapies for patients in areas such as immunology, immuno-oncology, and rare genetic diseases. Their pipeline includes AVTX-002, AVTX-007, and AVTX-006, with ongoing clinical programs. With a focus on Rare Pediatric and Orphan Diseases, Avalo Therapeutics aims to accelerate clinical development and increase the probability of success through strong scientific and clinical rationale.
Contacts

location

Rockville, MD, USA

Website URL

https://www.avalotx.com/

Social url

Similar Companies
1000
Leap Therapeutics
Leap TherapeuticsLeap Therapeutics develops cancer therapies by inhibiting tumor-promoting pathways and activating the immune system.
Leap Therapeutics

Leap Therapeutics

Leap Therapeutics develops cancer therapies by inhibiting tumor-promoting pathways and activating the immune system.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Cambridge, MA, USA

total rounds

10

total raised

$266.5M
Soleno Therapeutics
Soleno TherapeuticsSoleno Therapeutics is a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases.
Soleno Therapeutics

Soleno Therapeutics

Soleno Therapeutics is a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Biopharma, Health Care

Location

Redwood City, CA, USA

total rounds

5

total raised

$427.5M
Bayhill Therapeutics
Bayhill TherapeuticsBayhill Therapeutics develops therapeutics for autoimmune diseases.
Bayhill Therapeutics

Bayhill Therapeutics

Bayhill Therapeutics develops therapeutics for autoimmune diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Therapeutics, Pharmaceuticals

Location

Portola Valley, CA, USA

total rounds

4

total raised

$61.2M
Highlight Therapeutics
Highlight TherapeuticsHighlight Therapeutics develops RNA-based immuno-oncology therapies to combat cancer in patients.
Highlight Therapeutics

Highlight Therapeutics

Highlight Therapeutics develops RNA-based immuno-oncology therapies to combat cancer in patients.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Therapeutics, Health Care

Location

Paterna, Valencia, Spain

total rounds

3

total raised

$27.05M

Financials

Funding Rounds
3
3

Number of Funding Rounds

$231.5M

Money Raised

Their latest funding was raised on 27.03.2024. Their latest investor BVF Partners. Their latest round Post-IPO Equity

Date 
Funding Round 
Investors 
Money Raised 
Lead 
27.03.2024
Post-IPO Equity
7
$185M
Commodore Capital
Commodore Capital
02.02.2023
Post-IPO Equity
—
$15M
—
17.09.2021
Post-IPO Equity
—
$31.5M
—
Commodore Capital

Commodore Capital

Commodore Capital partners with biopharmaceutical companies to develop medical products that improve patients' lives.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

New York, NY, USA

count Of Investments

28
Co-Investors
Investors
7
1

Number of lead investors

7

Number of investors

Investor 
Lead 
Round 
Partners 
BVF Partners
No
Post-IPO Equity
—
Commodore Capital
Commodore Capital
Yes
Post-IPO Equity
—
OrbiMed
OrbiMed
No
Post-IPO Equity
—

BVF Partners

BVF Partners is a US-based venture capital firm that specializes in investing in small-cap biotechnology companies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Financial Services, Venture Capital, Biotechnology

count Of Investments

21
Commodore Capital

Commodore Capital

Commodore Capital partners with biopharmaceutical companies to develop medical products that improve patients' lives.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

New York, NY, USA

count Of Investments

28
OrbiMed

OrbiMed

OrbiMed is a healthcare-focused investment firm managing approximately $5 billion in assets.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Venture Capital, Health Care

Location

New York, NY, USA

count Of Investments

561

count Of Exists

82
Acquisitions
1
Acquiree Name 
Date 
Price 
Acquisition Name 
AlmataBio
AlmataBio
27.03.2024
$15M
Avalo Therapeutics-AlmataBio
AlmataBio acquired by Avalo Therapeutics

AlmataBio acquired by Avalo Therapeutics

acquirer

Avalo Therapeutics
Avalo Therapeutics

date

27.03.2024

type

Acquisition

price

$15M
AlmataBio

AlmataBio

AlmataBio specializes in antibody that effectively prevents hidradenitis suppurativa and various inflammatory diseases.

People

Founders
1

Isaac Blech

current job

Avalo Therapeutics
Avalo Therapeutics

organization founded

1
Isaac Blech

Isaac Blech

Employee Profiles
6
Stephen Smolinski
Stephen Smolinski

Stephen Smolinski

Chief Commercial Officer

Chief Commercial Officer

John Boland
John Boland

John Boland

Vice President, Clinical Operations

Vice President, Clinical Operations

Schond L. Greenway
Schond L. Greenway

Schond L. Greenway

Chief Financial Officer

Chief Financial Officer

James A. Harrell
James A. Harrell

James A. Harrell

Chief Commercial Officer

Chief Commercial Officer

Michael Cola
Michael Cola

Michael Cola

Chief Executive Officer, Chairman of the Board

Chief Executive Officer, Chairman of the Board

Isaac Blech

Isaac Blech

Founder & Vice Chairman

Founder & Vice Chairman

Activity

Recent News
4
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

week